Drug ID: | NPD3402 |
Drug Name: | ABT-107 |
Molecular Formula: | C19H20N4O |
Canonical SMILES: | c1cc2c([nH]1)ccc(c2)c1ccc(nn1)O[C@H]1CN2CCC1CC2 |
Standard InCHI: | InChI=1S/C19H20N4O/c1-2-16-15(5-8-20-16)11-14(1)17-3-4-19(22-21-17)24-18-12-23-9-6-13(18)7-10-23/h1-5,8,11,13,18,20H,6-7,9-10,12H2/t18-/m0/s1 |
Standard InCHIKey: | LUKNJAQKVPBDSC-SFHVURJKSA-N |
Max Developmental Stage: | Phase 1 |
Max Developmental Stage Source: | ChEMBL |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
TTD | DIB011219 |
DrugBank | |
ChEMBL | |
IUPHAR/BPS | |
PharmaGKB | |
KEGG Drug | |
PubChem CID | |
ChEBI | |
CAS Number |
Molecular Weight | 320.16 |
ALogP | -1.459 |
MLogP | 3 |
XLogP | 3.2 |
HDA | 4 |
HBD | 1 |
Rotatable Bonds | 3 |
TPSA | 54.04 |
RO5 Violation | 0 |